Antiphospholipid Syndrome

• 

  Subject Areas on Research

  • 'Criteria' aPL tests: report of a task force and preconference workshop at the 13th International Congress on Antiphospholipid Antibodies, Galveston, Texas, April 2010. 
  • 14th International Congress on Antiphospholipid Antibodies Task Force. Report on antiphospholipid syndrome laboratory diagnostics and trends. 
  • 14th International Congress on Antiphospholipid Antibodies: task force report on antiphospholipid syndrome treatment trends. 
  • 16th International Congress on Antiphospholipid Antibodies Task Force Report on Antiphospholipid Syndrome Treatment Trends. 
  • A possible coagulation-independent mechanism for pregnancy loss involving β(2) glycoprotein 1-dependent antiphospholipid antibodies and CD1d. 
  • Abnormal optical waveform profiles in coagulation assays from patients with antiphospholipid antibodies. 
  • Adrenal hemorrhage in patients with primary antiphospholipid syndrome: imaging findings. 
  • Anatomic distribution of venous thrombosis in patients with antiphospholipid antibody: imaging findings. 
  • Anti-beta(2)-glycoprotein I antibody-mediated inhibition of activated protein C requires binding of beta(2)-glycoprotein I to phospholipids. 
  • Anti-phospholipid antibodies in patients with multiple sclerosis and MS-like illnesses: MS or APS? 
  • Antiphospholipid Syndrome Clinical Research Task Force report. 
  • Antiphospholipid antibodies. 
  • Antiphospholipid antibody syndrome: current concepts. 
  • Antiphospholipid syndrome and cardiac surgery: management of anticoagulation in two patients. 
  • Antiphospholipid syndrome with catastrophic bleeding and recurrent ischemic strokes as initial presentation of systemic lupus erythematosus. 
  • Antiphospholipid syndrome. 
  • Antiphospholipid syndrome: advances in diagnosis, pathogenesis, and management. 
  • Antiphospholipid syndrome: laboratory testing and diagnostic strategies. 
  • Assessment of the 2006 revised antiphospholipid syndrome classification criteria. 
  • Autoantibodies before the clinical onset of systemic lupus erythematosus. 
  • Beta2-glycoprotein I-dependent anticardiolipin antibodies preferentially bind the amino terminal domain of beta2-glycoprotein I. 
  • Catastrophic antiphospholipid syndrome after cardiac surgery. 
  • Catastrophic antiphospholipid syndrome with concurrent thrombotic and hemorrhagic manifestations. 
  • Coagulation disorders and their cutaneous presentations: Pathophysiology. 
  • Detection of antibody-mediated reduction of annexin A5 anticoagulant activity in plasmas of patients with the antiphospholipid syndrome. 
  • Development of a New International Antiphospholipid Syndrome Classification Criteria Phase I/II Report: Generation and Reduction of Candidate Criteria. 
  • Diagnosis of pulmonary embolism. 
  • Disseminated thrombosis in primary antiphospholipid syndrome: MR findings. 
  • Effects of inherited thrombophilic mutations in an adolescent with antiphospholipid syndrome and systemic lupus erythematosus. 
  • Familial antiphospholipid antibody syndrome: criteria for disease and evidence for autosomal dominant inheritance. 
  • Fetal renal vein thrombosis, hydrops fetalis, and maternal lupus anticoagulant. A case report. 
  • From antiphospholipid syndrome to antibody-mediated thrombosis. 
  • Gene-expression patterns predict phenotypes of immune-mediated thrombosis. 
  • Guidance from the Scientific and Standardization Committee for lupus anticoagulant/antiphospholipid antibodies of the International Society on Thrombosis and Haemostasis: Update of the guidelines for lupus anticoagulant detection and interpretation. 
  • How I treat catastrophic thrombotic syndromes. 
  • Hypercoagulable states: a review. 
  • Laboratory criteria for antiphospholipid syndrome: communication from the SSC of the ISTH. 
  • Laboratory criteria for antiphospholipid syndrome: reply. 
  • Management of lepirudin therapy for a patient with antiphospholipid antibody syndrome using the whole blood ecarin clot time and activated partial thromboplastin time. 
  • Managing contraception and pregnancy in the rheumatologic diseases. 
  • Managing oral anticoagulant therapy. 
  • Point-of-care testing of the international normalized ratio in patients with antiphospholipid antibodies. 
  • Polypoidal choroidal vasculopathy and systemic lupus erythematosus. 
  • Rituximab for successful management of probable pediatric catastrophic antiphospholipid syndrome. 
  • Society for Maternal-Fetal Medicine Consult Series #64: Systemic lupus erythematosus in pregnancy. 
  • Symptoms of Mild Traumatic Brain Injury Unmask Autoimmune Disease. 
  • Systemic thrombosis in patients with antiphospholipid antibodies: lesion distribution and imaging findings. 
  • Testing for antiphospholipid antibodies with solid phase assays: guidance from the SSC of the ISTH. 
  • The antiphospholipid syndrome: what are we really measuring? How do we measure it? And how do we treat it? 
  • The importance of pregnancy planning in lupus pregnancies. 
  • The role of antibody polyspecificity and lipid reactivity in binding of broadly neutralizing anti-HIV-1 envelope human monoclonal antibodies 2F5 and 4E10 to glycoprotein 41 membrane proximal envelope epitopes. 
  • Thoracic imaging features of patients with antiphospholipid antibodies. 
  • Thrombosis and the antiphospholipid syndrome. 
  • Update of the guidelines for lupus anticoagulant detection. Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis. 
  • Vascular disease in the antiphospholipid syndrome: a comparison with the patient population with atherosclerosis. 
  • Warfarin in antiphospholipid syndrome--time to explore new horizons. 
• 

  Keywords of People

  • Allen, Nancy Bates, Professor Emeritus of Medicine, Medicine, Rheumatology and Immunology
  • Schanberg, Laura Eve, Professor of Pediatrics, Pediatrics, Rheumatology